Over 91 percent of the total revenue of the Russian pharmaceutical company R-Pharm came from sales of medicines for treatment of the coronavirus (COVID-19) in 2021. Furthermore, COVID-19 drug sales accounted for almost 46 percent of the revenue of Pfizer in Russia.
Share of medicines for COVID-19 treatment in the total revenue in Russia in 2021, by pharmaceutical company
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Pharmaceutical industry in Russia
Overview
8
- Premium Statistic Pharmaceutical market size in Russia 2012-2025
- Premium Statistic Pharmaceutical market size in Russia 2017-2025, by segment
- Premium Statistic Pharmaceutical sales volume in Russia 2020-2023, by segment
- Basic Statistic Commercial pharma market value in Russia monthly 2021-2023
- Premium Statistic Retail sales of medicines in Russia 2015-2022
- Premium Statistic Pharmaceutical production value in Russia 2015-2023
- Premium Statistic Pharmaceutical sales volume share in Russia 2023, by price category
- Premium Statistic Inflation on pharmaceuticals in Russia 2008-2023
Segments
8
- Premium Statistic Pharmaceutical revenue share in Russia 2023, by segment
- Premium Statistic Generic and original medication sales volume share in Russia 2020-2023
- Basic Statistic Medicine sales value share in Russia 2020-2023, by origin
- Premium Statistic Medication sales volume share in Russia 2020-2023, by type
- Premium Statistic Revenue of the analgesics industry in Russia 2018-2029
- Premium Statistic Revenue of the digestives & intestinal remedies industry in Russia 2018-2029
- Premium Statistic Revenue of the cold & cough remedies industry in Russia 2018-2029
- Premium Statistic Revenue of the vitamins & minerals industry in Russia 2018-2029
Companies and brands
8
- Premium Statistic Leading pharma corporations in Russia 2023, by sales share
- Premium Statistic Leading pharmaceutical producers in Russia 2023, by revenue
- Premium Statistic Leading pharma distributors in Russia 2023, by revenue
- Premium Statistic Most popular medications in Russia 2023, by sales value
- Premium Statistic Most sold mass pharmaceutical cosmetic brands in Russia 2023
- Premium Statistic Most sold premium pharmaceutical cosmetic brands in Russia 2023
- Premium Statistic Most sold healing pharmaceutical cosmetic brands in Russia 2023
- Premium Statistic Highest-earning brands of biologically active additives in Russia 2023
Pharmacies
4
Online retail
6
- Premium Statistic Online pharmacy market revenue in Russia 2020-2023
- Premium Statistic Online pharmacy order count in Russia 2018-2024
- Premium Statistic Online pharmacy average order value in Russia 2018-2023
- Premium Statistic Share of online pharmacies in Russia 2022, by location
- Premium Statistic E-pharmacy delivery methods in Russia 2022
- Premium Statistic Pharma e-commerce revenue growth in Russia 2022-2023, by platform
Further Content: You might find this interesting as well
DSM Group. (February 15, 2022). Share of medicines for COVID-19 treatment in the total revenue in Russia in 2021, by pharmaceutical company [Graph]. In Statista. Retrieved May 21, 2024, from https://www.statista.com/statistics/1296847/covid-19-medicine-share-in-pharma-company-revenues-russia/
DSM Group. "Share of medicines for COVID-19 treatment in the total revenue in Russia in 2021, by pharmaceutical company." Chart. February 15, 2022. Statista. Accessed May 21, 2024. https://www.statista.com/statistics/1296847/covid-19-medicine-share-in-pharma-company-revenues-russia/
DSM Group. (2022). Share of medicines for COVID-19 treatment in the total revenue in Russia in 2021, by pharmaceutical company. Statista. Statista Inc.. Accessed: May 21, 2024. https://www.statista.com/statistics/1296847/covid-19-medicine-share-in-pharma-company-revenues-russia/
DSM Group. "Share of Medicines for Covid-19 Treatment in The Total Revenue in Russia in 2021, by Pharmaceutical Company." Statista, Statista Inc., 15 Feb 2022, https://www.statista.com/statistics/1296847/covid-19-medicine-share-in-pharma-company-revenues-russia/
DSM Group, Share of medicines for COVID-19 treatment in the total revenue in Russia in 2021, by pharmaceutical company Statista, https://www.statista.com/statistics/1296847/covid-19-medicine-share-in-pharma-company-revenues-russia/ (last visited May 21, 2024)
Share of medicines for COVID-19 treatment in the total revenue in Russia in 2021, by pharmaceutical company [Graph], DSM Group, February 15, 2022. [Online]. Available: https://www.statista.com/statistics/1296847/covid-19-medicine-share-in-pharma-company-revenues-russia/